مؤتمر
First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted Therapy study)
| العنوان: | First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted Therapy study) |
|---|---|
| المؤلفون: | Ascierto PA, Mandalà M, Ferrucci PF, Rutkowski P, Guidoboni M, Arance Fernandez AM, Ferraresi V, Maiello E, Guida M, Del Vecchio M, Fierro MT, Queirolo P, Lebbè C, Helgadottir H, Melero I, Palmieri G, Giannarelli D, Grimaldi AM, Dummer R, Chiarion-Sileni V |
| المساهمون: | Ascierto, Pa, Mandalà, M, Ferrucci, Pf, Rutkowski, P, Guidoboni, M, Arance Fernandez, Am, Ferraresi, V, Maiello, E, Guida, M, Del Vecchio, M, Fierro, Mt, Queirolo, P, Lebbè, C, Helgadottir, H, Melero, I, Palmieri, G, Giannarelli, D, Grimaldi, Am, Dummer, R, Chiarion-Sileni, V |
| بيانات النشر: | Elsevier NLD |
| سنة النشر: | 2020 |
| المجموعة: | Università degli Studi di Ferrara: CINECA IRIS |
| نوع الوثيقة: | conference object |
| وصف الملف: | STAMPA |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/wos/WOS:000573469102673; ispartofbook:Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020; ESMO Virtual Congress2020; volume:31; issue:S4; firstpage:S1173; lastpage:S1174; numberofpages:2; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/11392/2530081Test; https://www.sciencedirect.com/science/article/pii/S0923753420423579Test |
| DOI: | 10.1016/j.annonc.2020.08.2275 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2020.08.2275Test https://hdl.handle.net/11392/2530081Test https://www.sciencedirect.com/science/article/pii/S0923753420423579Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.15BE44D2 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2020.08.2275 |
|---|